Trust Company’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$158K Sell
603
-4
-0.7% -$1.05K 0.01% 199
2026
Q2
$134K Sell
607
-7
-1% -$1.94K 0.01% 203
2026
Q1
$181K Sell
614
-285
-32% -$84.7K 0.02% 181
2025
Q4
$245K Sell
899
-198
-18% -$53.8K 0.02% 157
2025
Q3
$296K Sell
1,097
-388
-26% -$106K 0.03% 122
2025
Q2
$409K Sell
1,485
-298
-17% -$81K 0.05% 96
2025
Q1
$473K Sell
1,783
-18
-1% -$4.44K 0.06% 94
2024
Q4
$418K Buy
1,801
+957
+113% +$220K 0.05% 104
2024
Q3
$186K Buy
+844
New +$175K 0.02% 136

Other funds holding CME

Trust Company's CME Position: Q3 2026 in Review

Trust Company reduced its CME Group (CME) stake by 0.66% in Q3 2026, selling an estimated $1.05K and leaving 603 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #199.

Trust Company first reported a position in CME in Q3 2024 and has held it in 9 quarters since. The position peaked at $473K in Q1 2025. 59 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Trust Company held 603 shares of CME Group worth $158K as of Q3 2026.
  • Trust Company sold 4 CME Group shares in Q3 2026, an estimated $1.05K.
  • CME Group made up 0.01% of Trust Company's portfolio in Q3 2026, its #199 holding.
  • Trust Company first reported a position in CME Group in Q3 2024 and has held it in 9 quarters since.
  • Trust Company's CME Group position peaked at $473K in Q1 2025.
  • 59 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.